Cian Healthcare Ltd vs Divi's Laboratories Limited

A side-by-side comparison of Cian Healthcare Ltd (542678) and Divi's Laboratories Limited (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads 542678 vs DIVISLAB on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth01
  • Size & financial health03

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
94.52
0.00
P/B ratio
14.90
0.00%
Dividend yield
0.32%
₹-9.32
EPS
₹96.75

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-49.20%
Return on equity
15.32%
-16.00%
Return on capital
20.35%
-24.00%
EBITDA margin
32.59%
-82.14%
Net margin
24.32%

Growth

DIVISLAB takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-25.97%
Revenue CAGR (3Y)
10.78%
—
Profit CAGR (3Y) even
12.09%

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹2.45L Cr
₹28 Cr
Revenue
₹10,560 Cr
₹-23 Cr
Net profit
₹2,568 Cr
0.00
Debt / equity even
0.00
Cian Healthcare Ltd
  • + ["Company has reduced debt.", "Promoter holding has increased by 67.9% over last quarter."]
  • − ["Stock is trading at 3.92 times its book value", "Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -17.4% over past five years.", "Company has a low return on equity of -18.6% over last 3 years.", "Company might be capitalizing the interest cost", "Company has high debtors of 163 days."]
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.48 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Cian Healthcare Ltd full analysis Divi's Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

542678 vs DIVISLAB: Share Price, Valuation & Which to Buy | DocStoX